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Renal histology remains the keystone of diagnosis in most
parenchymal renal diseases and especially in glomerulopathies
[1—3]. Sampling of renal tissue by percutaneous needle biopsy
was described by Iversen and Brun in 1951 [4}. This procedure
is usually safe, provided contraindications are respected [5—10].
Such contraindications include uncontrolled hypertension
and/or bleeding disorders, which can favor severe perirenal
hematoma. Even when these contraindications are heeded,
systematic computerized tomography (CT) showed that the
incidence of perirenal hematoma discovered by CT scan (irre-
spective of its clinical manifestation) is 57 to 85% [11, 12].
In the absence of contraindications, there are patients in
whom the slightest possibility of a complication necessitating
lombotomy for hemostasis would be ethically incompatible with
renal biopsy. This is the case, for instance, in patients with
morbid obesity or with chronic respiratory insufficiency, in
whom general anesthesia might represent a considerable haz-
ard. Finally, there are cases where the size or the anatomical
location of the kidney makes renal tissue sampling difficult or
impossible. Ultrasound or CT scan-guided biopsy [13—15] does
not always obviate such pitfalls. Other, more invasive methods
have been proposed to sample kidney tissue, for instance by
means of a short lombotomy [16—21], but this approach, which
in addition necessitates the use of an operating room and
several days of hospitalization, is similarly inapplicable in a
patient with severe bleeding disorder or morbid obesity.
We have described a novel technique of renal biopsy using
the transjugular route, inspired from that used for liver biopsy
in patients with clotting disorders in whom the percutaneous
route would similarly be precluded [22—24]. This new technique
was published in abstract form [25], and we reported our
preliminary results on 50 cases [261. The goal of this Technical
Note is to analyze our present experience on 200 procedures
carried out in 195 patients.
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Methods
Material
As described previously [24], we initially tested the proce-
dure in five cadavers with normal-sized kidneys. We first
determined that the curvature and rigidity of the liver biopsy
needle was compatible with biopsy of the right kidney, due to
the favorable vertical obliquity of the right renal vein (Fig. 1).
Conversely, the long horizontal course and numerous collater-
als of the left renal renal vein appeared incompatible with the
procedure. Transjugular renal biopsy was thus restricted to the
right kidney.
The conventional liver biopsy set appeared inadequate for the
purpose of renal biopsy, as the needle's course outside the
catheter was too long and its tip perforated the renal capsule,
indicating that, using this set in vivo, the patient would be
exposed to bleeding into the retroperitoneal space. Conse-
quently, the equipment used for liver biopsy was modified and
the material that has been safely used for the 200 procedures
described here has the following characteristics: catheter length
62.5 cm, gauge 9 F (2.97 mm), precurved at 45°; needle length
63.8 cm, gauge 15 G (1.84 mm), with a reversed bevel at 45°
(William Cook-Europe, Bjaeverskov, Denmark).
Methods
In each instance informed consent was obtained from the
patient or his family after detailed explanation as to the neces-
sity for renal tissue sampling, the hazards of a more conven-
tional approach and the hitherto experimental nature of the
jugular route in his/her particular case.
All procedures were carried out by the same operator (F.M.)
in a radiology department and were monitored under fluoro-
scopic control. After the procedure had been completed, the
patient was returned to bed and surveillance was the same as in
conventional renal or liver biopsy. Systematic renal ultrasound
examination was performed within 24 hours after the proce-
dure, irrespective of presence or absence of clinical signs of
perirenal hematoma. Computerized tomography was not sys-
tematic and was done in only three cases with clinically
significant hematomas.
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Table 1. Reasons for selecting the transvenous route for renal biopsy
in 195 patients
_______________
Bleeding disordera
Necessity for combined renal + hepatic biopsy"
Poor backgrounds
Uncontrolled hypertension
Morbid obesity
Failure of percutaneous route
Solitary right kidney
_______
Thirty patients had more than one contraindication to percutaneous
renal biopsy, which explains the total number of 282 contraindications
in 195 patients.
a Defined as prothrombin activity < 50% of normal controls, and/or
platelet counts < 100,0001mm3, and/or Ivy's bleeding time > 10 mm,
and/or cephalin kaolin time > 1.5 of normal controls.
b Most of these patients had bleeding disorders due to liver disease.
In some, however, the transjugular route was selected for renal biopsy
in order to avoid two separate biopsy procedures (liver, then kidney or
vice-versa). This policy reduced the length of hospitalization by several
days.
Defined as patients with unacceptable risk of lombotomy or of
angiography in case of percutaneous biopsy complication. Most of
these cases were patients with severe chronic respiratory insufficiency.
Three patients were biopsied while receiving mechanical respiratory
assistance.
Fig. 1. Right renal vein phiebography carried out at the time of
transjugular renal biopsy. This photograph shows the catheter wedged
into the lower pole of the right kidney. The oblique, and sometimes
almost vertical course of this vein is favorable to the insertion of the
hardly flexible biopsy needle. This would not be feasible on the left side.
The insert depicts the course of the catheter from the jugular vein to the
right kidney.
Conduct of the procedure
In the light of our experience, we recommend the following
steps.
(1) Administer mild sedation, for example chlorazepate, 30
minutes before beginning the procedure; place the patient in
supine position on the radiology table, (2) After local anesthe-
sia, puncture the right internal jugular vein and introduce a
vessel dilator. (3) Insert a wire guide into the inferior vena cava
under x-ray control. (4) Slip the renal biopsy catheter onto the
guide, place the catheter in the right renal vein and wedge at the
lower pole of the right kidney. Check its position using 2 ml of
contrast medium. (5) Fill the transvenous renal biopsy needle
with saline and insert it into the catheter. (6) Connect the needle
to a glass syringe filled with saline, quickly advance the needle
under vacuum aspiration beyond the tip of the catheter, and
withdraw. Flush the renal tissue sample, which is retained in
the syringe, needle or catheter.
The procedure can be repeated in order to obtain fragments
for light microscopy and immunofluorescence. However, we
observed that repeating the passes within the same branch of
the renal vein seemed to progressively drill a deeper channel
within the renal tissue, thus leading the tip of the needle closer
to the capsule and thereby presumably increasing the risk of
perforation. Therefore, we decided to limit the procedure to a
maximum of three passes. In 15 cases a fourth pass was
considered necessary. In these cases, we slightly retracted the
catheter, changed its orientation, inserted it into another
venous branch, checked its position with 2 ml of contrast
medium, used a new needle and took a fourth core of tissue. In
no instance were more than four passes carried out.
The same catheter and needle can be used for taking a liver
sample after retracting the catheter and inserting it into a
hepatic vein.
Results
Patients
One hundred and ninety-five patients (135 males and 60
females) were investigated by transjugular biopsy of the right
kidney. Their mean age was (mean SD) 53 16 years with
extremes of 15 and 87 years. The reasons for choosing the
transjugular route are shown in Table 1. The major reason
consisted of bleeding disorders, which explains the large num-
ber of cirrhotics (49 patients) in this series. All patients suffered
from conditions which justified the need for renal tissue sam-
pling, such as proteinuria and microhematuria, nephrotic syn-
drome, or renal insufficiency of unclear etiology. Six cases were
patients with an indication for liver transplantation in whom
final decision depended on the nature of renal insufficiency,
with doubt as to functional (hepatorenal syndrome) versus
organic, renal failure. In three the decision involved combined
liver and kidney transplantation.
Quality of renal tissue sampling
All biopsies were studied by the same pathologist (P.C.).
Transvenous renal biopsy yielded renal tissue in 176 of 200
procedures (88%), and the renal biopsy sample was diagnosti-
cally useful in 146 of 176 (83%).
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Fig. 2. Number of glomeruli found in 176 of 200 transjugular renal
biopsy procedures where renal tissue was obtained. This number
regards the fragment destined for light microscopy. It therefore under-
estimates the total number of glomeruli present in all the cores yielded
by the procedure, as glomeruli were also usually present in the
fragments processed for immunofluorescence.
The number of glomeruli yielded by transvenous renal biopsy
is represented in Figure 2. This number corresponds to the
count made on the core destined for light microscopy. Care was
taken to avoid counting the same glomeruli more than once.
The average number of glomeruli was 10 6, with a minimum
of one and a maximum of 35. In 19 of 25 cases with less than 5
glomeruli on the transjugular renal biopsy sample, diagnosis
was nevertheless possible due to the diffuse nature of the
glomerulopathy. This included cases with IgA mesangial depos-
its, membranous glomerulopathy, renal amyloidosis or light
chain deposition. In one case with rapidly progressive renal
insufficiency, acute streptococcal glomerulonephritis was diag-
nosed on the one and only available glomerulus, thus avoiding
the aggressive treatment which had been considered in view of
possible crescentic glomerulopathy.
The quality of histologically usable renal tissue increased
with time, that is, with the skill of the operator. Thus, the failure
rate was seven in the first 20 procedures (35%) and seven in the
last 50 (14%).
Complications of transjugular renal biopsy
Renal function was unchanged after the procedure, except in
two patients who bled and in whom transfusions were neces-
sary. In these two cases the rise in serum creatinine was
reversible. Contrast medium toxicity was excluded, especially
in view of the small amount of iodine injected (2 to 4 ml), an
amount which is in the order of 3 percent of the dose used for
intravenous pyelography.
Transjugular renal biopsy was uneventful in 179 of 200
procedures. In six patients a small, non-clinically significant
perirenal hematoma was detected by systematic ultrasound
examination. In four other cases the biopsy was followed by
clinically significant perirenal hematoma which in three cases
necessitated transfusion of 4, 3 and 2 units of packed red cells,
respectively. In 15 cases the biopsy was followed by macro-
scopic hematuria. This bleeding lasted a few hours in 13
patients, and two and four days, respectively, in the two others.
In the latter case, the hematuria, although transient was abun-
dant and necessitated transfusion of 4 units of blood. No other
complication was observed.
IgA nephropathy 36
Diabetic glomerulopathy 30
Focal segmental glomerulosclerosis 22
Lupus nephritis 14
Membranous GN 11
Minimal change disease 10
Obsolescent glomeruli 7
Chronic interstitial nephritis 6
Crescentic GN 6
Acute UN 5
Acute tubular necrosis 4
Light chain disease 3
Amyloidosis 3
Polyarteritis nodosa 2
Total Tj
Case by case analysis of the three patients who had signifi-
cant perirenal hematoma showed that they all had severe
clotting disorders and that 2/3 had small, contracted kidneys.
Pathological yield of transfugular renal biopsy
The yield of this technique is illustrated in Figures 2 and 3 and
in Table 2. The three most frequent histological diagnoses in
this series were diabetic glomerulosclerosis, IgA nephropathy
(Berger's disease or IgA nephropathy due to cirrhosis of the
liver) and focal segmental glomeruloscierosis (FSGS). Interest-
ingly, FSGS was found in two of five biopsies of a solitary right
/
No renal
tissue: 24/
Recurrent 1
renal vein: 8
Total number of
procedures: 200
Renal tissue: 176N
_ _
No renal tissue in Glomeruli in jiles
spite of correct sample: 159 only: 17
posItion: 16
Contributive to Not contributive
diagnosis: 146 to diagnosis: 13/N
confirmed presumed Corrected erroneous pre-
diagnosis: 92 biopsy diagnosis: 54
Did not influence Influenced treatment
treatment strategy: strategy: 26
120 _____________________
Fig. 3. Diagnostic value of transjugular renal biopsy.
Table 2. Histological diagnosis in 159 procedures yielding renal
tissue
448 Ma! ci al: Transfugular biopsy
kidney in patients who had been nephrectomized in the past and
suffered from nephrotic syndrome and chronic renal insuffi-
ciency.
Discussion
The acquired experience is now sufficient to discuss the pros
and cons of transjugular renal biopsy versus more conventional
techniques of renal tissue sampling. Its major advantage is to
afford histological diagnosis in patients with bleeding disorders
or with a compromised background which would preclude
percutaneous needle biopsy, or surgical biopsy of the kidney.
This does not mean, however, that the transjugular route is
applicable in all patients with a contraindication to conventional
renal biopsy, or that the technique is devoid of risk. The
number of glomeruli yielded by transjugular renal biopsy is
often limited. This is especially the case in patients with chronic
renal failure and small, contracted kidneys, in whom the
procedure often yields few obsolescent glomeruli surrounded
by a small piece of fibrous tissue. Such a small sample may lead
to misclassification of disease severity and make exclusion of
focal disease difficult [271. Perirenal hematoma remains a haz-
ard, especially when the kidney is atrophic, with reduction of
the distance between the tip of the catheter and the renal
capsule, allowing perforation by the needle. The possibility of
bleeding into the urinary tract remains, and it is noteworthy that
the two cases where hematuria was abundant did not exhibit
particularly severe bleeding disorders. Also, transjugular renal
biopsy is time consuming and necessitates occupation of a
radiology room, adding to the cost of the procedure; this should
be considered among its drawbacks. Finally, there are cases
where transjugular renal biopsy is not feasible for underlying
anatomic or morbid associated conditions. Three pitfalls should
be cited here: 1) thrombosis or congenital absence of right
internal jugular vein; 2) recurrent course of right renal vein; and
3) thrombosis of the inferior vena cava and/or right renal vein.
These considerations imply that transjugular renal biopsy
cannot be considered a routine method of renal sampling.
Despite this reservation, we feel that the risk/benefit ratio of
this new method justifies its application in cases where so far no
nephrologist would have envisaged the possibility of reaching a
histological diagnosis. Can one more specifically define such
cases? In the light of our experience we would propose this
schematic classification:
1) Cases representing a good indication of the transfugular
route for renal tissue sampling. 1.1. Patients with bleeding
disorders precluding any conventional form of renal biopsy.
1.2. Patients with a poor background (in a broad sense),
which would represent a vital risk in case of biopsy complica-
tion requiring surgery.
1.3. Patients treated with mechanical ventilatory assistance,
precluding percutaneous renal biopsy in the supine position.
2) Cases representing a possible indication of the transfugu-
tar route for renal tissue sampling. 2.1. Patients enrolled in
prospective trials including repeat renal biopsy and in whom
investigators wish to minimize hazards of renal biopsy.
2.2. Patients with a solitary right kidney.
3) Cases representing a poor indication of the transjugular
route for renal tissue sampling. 3.1. Patients with small, con-
tracted kidneys due to chronic renal failure.
3.2. Patients with dilated urinary tract and thin renal cortex.
We stated above that the procedure requires a skilled oper-
ator. Is this a factor limiting the development of transjugular
biopsy in nephrology units? In fact, this last point does not
seem to represent a major problem. First, any hepatologist or
radiologist familiar with the technique of transjugular liver
biopsy can readily envisage carrying out renal biopsy with the
modified equipment. Second, nephrologists and radiologists
from three other institutions who requested training achieved a
success rate in obtaining renal tissue that was roughly compa-
rable to ours after having attended approximately ten proce-
dures.
Finally, the question can be raised whether, despite its
somewhat cumbersome and costly aspects, the jugular route
might be proposed in cases with no contraindication to conven-
tional, percutaneous renal biopsy, especially in view of the
remarkably low rate of bleeding complications. This approach
(as specified in the legend of Table 1) was indeed deliberately
adopted in some patients in whom renal biopsy was carried out
together with liver biopsy, despite absence of specific contrain-
dication to the percutaneous route. What about cases with no
indication for hepatic biopsy? The answer is not straightfor-
ward. The weak point of transvenous renal biopsy, which is the
often relatively small fragment of renal tissue it yields, must be
weighed against its safety. Increasing the number of passes
would add to the number of cores usable for histology, but
would also increase the hazards of the procedure. In answer,
we would tentatively suggest that in selected cases, the jugular
route might be used in a fragile patient, especially when the
diffuse nature of the renal lesions can be anticipated, thus
allowing reasonable hope of diagnosis despite a limited number
of glomeruli. Among other examples, suspicion of membranous
glomerulopathy or of light chain amyloidosis in a patient with
malignancy and nephrotic syndrome, and perhaps prospective
studies on diabetic nephropathy might be proposed.
Reprint requests to A lain Meyrier, M.D., Service de Nephro/ogie,
Hôpital Avicenne, 93009 Bobigny, France.
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